JPRN-UMIN000015431已完成2 期
Phase II trial of a low dose nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer. - Phase II trial of a low dose nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unrecectable or recurrent advanced gastric cancer.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 34
研究概览
简要总结
Anticancer Res. 2018 Dec;38(12):6911-6917. doi: 10.21873/anticanres.13068.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1.With history of receiving paclitaxel treatment 2.With serious drug allergy 3.With servaral comorbid disease poorly controlled diabetes poorly controlled hypertension liver cirrhosis, liver failure renal failure intestitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema active infectious disease heart failure, myocardial infarction, angina pectoris or ECG abnormalities within 6 months 4.With active anothor cancer 5.With peripheral neuropathy greater than grade2 6.With HBs antigen positive 7.With pregnant or nursing women 8.Cases who physician judged improper to entry this trial
研究者
相似试验
尚未招募
2 期
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.Histological or Cytological Confirmed Stage Ⅲ and Ⅳa ThymomaNCT05816694Peng Liu50
已完成
2 期
ABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerBreast CancerNCT00110084Mayo Clinic50
已完成
不适用
Phase II study of weekly nanoparticle albumin-bound paclitaxel for patients with metastatic breast cancer (KSCOG-BC04)Breast CancerJPRN-UMIN000008861Department of Surgery, Kurume University School of Medicine55
招募中
2 期
Phase I Study of Nanoparticle albumin-bound paclitaxel and Cyclophosphamide combination chemotherapy for Patients with Metastatic Breast Cancer(GBCCSG-02)Primary breast cancerJPRN-UMIN000009973Gunma Breast Clinical Conference Study Group(GBCCSG)12
Unknown
2 期
Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerAdvanced Pancreatic CancerNCT02124317Chinese PLA General Hospital60
